Cleary Gottlieb represented Biomet, Inc. in the refinancing of its existing Euro-denominated extended term loans and US dollar-denominated extended term loans with the proceeds of new US dollar-denominated term loans with improved pricing. The transaction closed on September 25, 2013.
Biomet designs, manufactures and markets a diverse portfolio of reconstructive, fixation and other products used primarily by musculoskeletal medical specialists.
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.
